Rankings / Metabolic Health

Berberine

Metabolic Health · AMPK activator / natural

Also known as: Dihydroberberine ·BBR

Tier B-

ampkpcsk9microbiomebiguanideotcmtor-inhibitionanti-inflammatory
6.3 / 10
Tier B-
Ev 6 Bn 5 Sf 7

Bottom line

Read Off Label grades Berberine as B- (6.3/10) based on moderate evidence, moderate benefit magnitude, and a low-med-risk safety profile.

The 'nature's Ozempic' TikTok rebrand inflated hype beyond evidence.

Studied, labeled, or reported-use context: 500 mg 2-3x/day with meals; dihydroberberine (Glucovantage) claims better bioavailability — OTC; not individualized guidance.

If you were testing this on yourself

Two properties decide whether an n-of-1 experiment is readable and recoverable. These describe the experiment — they are not a judgment about whether to run it, and nothing here is a recommendation.

Can you undo it?

Reverses on stopping

Reversible. GI effects stop with the dose. The interaction risk is the real issue — it inhibits CYP3A4 and raises levels of many other drugs.

Can you tell if it worked?

Readable — Days on a CGM; 3 months for HbA1c to reflect the change

Fasting glucose, HbA1c, or a continuous glucose monitor. Genuinely measurable at home.

What would fool you Diet changes made at the same time will dominate any glucose readout. HbA1c lags by about three months, so testing early shows the old picture. If you take other medications, the interaction is a bigger consideration than the result.

What the evidence says

The 'nature's Ozempic' TikTok rebrand inflated hype beyond evidence. Legitimate mechanism and moderate effects on glucose and lipids. CYP3A4 interactions are underappreciated — affects many common drugs including statins, calcium channel blockers, warfarin. Poor bioavailability native — dihydroberberine has better PK.

Mechanism

Alkaloid from Berberis/goldenseal/Coptis; AMPK activator (metformin-like); inhibits PCSK9 expression; modulates gut microbiome; glucose-lowering via multiple mechanisms

Studied, labeled, or reported dose & route

500 mg 2-3x/day with meals; dihydroberberine (Glucovantage) claims better bioavailability

This records doses and routes described in studies, approved labeling, clinical practice, or documented use. It is not individualized guidance and does not establish safety; context changes with indication, formulation, health history, monitoring, and other medicines.

Common questions

What does the evidence show about Berberine's effects?
Read Off Label rates the evidence for Berberine as Moderate and the benefit magnitude as moderate, producing an overall grade of B- (6.3/10). The 'nature's Ozempic' TikTok rebrand inflated hype beyond evidence.
What safety findings are reported for Berberine?
Berberine has a low-med risk profile in the database. Low-Med (GI upset common — diarrhea, cramping; significant CYP3A4 inhibition → drug interactions; not safe in pregnancy) Legal status: OTC.
What doses or routes are reported for Berberine?
500 mg 2-3x/day with meals; dihydroberberine (Glucovantage) claims better bioavailability This is context from studies, approved labeling, clinical practice, or documented use; it is not individualized guidance and does not establish safety.
How does Berberine work?
Alkaloid from Berberis/goldenseal/Coptis; AMPK activator (metformin-like); inhibits PCSK9 expression; modulates gut microbiome; glucose-lowering via multiple mechanisms

This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.